Most Active Biotech. Stocks: Ariad Pharmaceuticals, Sangamo Biosciences, Medivation Inc, PDL BioPharma Inc

Lakeway, TX -- (SBWIRE) -- 03/07/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares added 1.41% and is trading at $21.54. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.

How Should Investors Trade ARIA After The Solid Jump? Let’s Find Out Here

Sangamo Biosciences, Inc.(NASDAQ:SGMO) is lower 0.81% to $9.78. Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins.

Is SGMO Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

Medivation Inc(NASDAQ:MDVN) added 4.77 % and is trading at $47.68. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options. Together with its collaboration partner Astellas Pharma Inc. (Astellas), the Company is developing MDV3100 for multiple stages of advanced prostate cancer.

Is MDVN Buy After The Recent Price Movement? Find Out Here

PDL BioPharma Inc.(NASDAQ:PDLI) fell 0.07 % and is trading at $6.97. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

Is PDLI Buy After The Recent Price Movement? Find Out Here

About vbtrendreport.com
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.